Leerink Partners Boosts CVS Health (NYSE:CVS) Price Target to $55.00
CVS Health (NYSE:CVS – Get Free Report) had its price target boosted by Leerink Partners from $51.00 to $55.00 in a report released on Tuesday. The firm presently has a “market perform” rating on the pharmacy operator’s stock. Leerink Partners’ price objective would indicate a potential downside of 13.02% from the company’s previous close. A […]
CVS Health (NYSE:CVS – Get Free Report) had its price target boosted by Leerink Partners from $51.00 to $55.00 in a report released on Tuesday. The firm presently has a “market perform” rating on the pharmacy operator’s stock. Leerink Partners’ price objective would indicate a potential downside of 13.02% from the company’s previous close. A […]
